Metis Global Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
VCM
VPM
Metis Global Partners's MRK Position: Q1 2026 in Review
Metis Global Partners reduced its Merck (MRK) stake by 3.1% in Q1 2026, selling an estimated $486K and leaving 133,464 shares worth $16.1M. The position accounts for 0.39% of the portfolio, ranked #35.
Metis Global Partners first reported a position in MRK in Q4 2021 and has held it in 18 quarters since. The position peaked at $18.9M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Metis Global Partners held 133,464 shares of Merck worth $16.1M as of Q1 2026.
- Metis Global Partners sold 4,207 Merck shares in Q1 2026, an estimated $486K.
- Merck made up 0.39% of Metis Global Partners's portfolio in Q1 2026, its #35 holding.
- Metis Global Partners first reported a position in Merck in Q4 2021 and has held it in 18 quarters since.
- Metis Global Partners's Merck position peaked at $18.9M in Q1 2024.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Metis Global Partners's 13F filing for Q1 2026, filed 7 May 2026.